lenalidomide has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Hao, G; He, Q; Liu, X; Lu, QR; Sattar, F; Wang, J; Weng, Q; Xu, Z; Yang, B; Yang, L; Zhang, Z; Zhao, M; Zheng, J | 1 |
| Celik, H; Chigurapati, S; Chigurupati, S; Das, S; Eitan, E; Fishbein, KW; Ghosh, P; Ghosh, S; Greig, NH; Hutchison, ER; Mattson, MP; Raymick, J; Sarkar, S; Sasaki, CY; Seal, S; Spencer, RG; Tweedie, D | 1 |
2 other study(ies) available for lenalidomide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization.
Topics: Animals; Autoimmunity; beta-N-Acetylhexosaminidases; Cell Count; Cell Differentiation; Central Nervous System; Clodronic Acid; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Immunologic Factors; Interleukin-10; Lectins; Lenalidomide; Liposomes; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Signal Transduction; STAT3 Transcription Factor; Th1 Cells; Th17 Cells | 2018 |
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Topics: Analysis of Variance; Animals; Autoimmunity; Cells, Cultured; Central Nervous System; Cerium; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Gene Expression Regulation; Immunologic Factors; Lenalidomide; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; RNA, Messenger; Thalidomide; Time Factors | 2015 |